Table 2.
Comparison of unfavorable functional status, AEs, and mortality rate between stent-implanted and medically managed group
| Variables | Stent-implanted group (n = 34) | Medically treated group (n = 29) | p value |
|---|---|---|---|
| Favorable functional status | 31 (93.9) | 17 (63.0) | 0.004 |
| mRS 0 | 12 (35.3) | 3 (10.3) | |
| mRS 1 | 11 (32.4) | 8 (27.6) | |
| mRS 2 | 8 (23.5) | 6 (20.7) | |
| Within-30-days AEs | 1 (2.9) | 1 (3.4) | 0.909 |
| Ischemic stroke* | 1 (2.9) | 0 | |
| TIA | 0 | 1 (3.4) | |
| FAEs | 1 (2.9) | 6 (20.7) | 0.042 |
| Ischemic stroke* | 0 | 4 (13.8)b | 0.040 |
| Myocardial infarction | 1 (2.9)a | 2 (6.9)c | 0.590 |
| Mortality | 1 (2.9) | 2 (6.9) | 0.590 |
Data are presented as numbers with percentages in parentheses.
*
Stroke in the territory of the qualifying artery.
a
One 75-year-old male with MCA involvement presenting with ischemic stroke (mRS 2) died 11 months after the procedure because of fatal myocardial infarction.
b
Including a 71-year-old male with ICA involvement presenting with TIA (mRS 5) who died 10 months after the study with massive ischemic stroke in the territory of his qualified artery.
c
Including a 74-year-old male with MCA involvement presenting with ischemic stroke (mRS 5) who died 12 months after the study because of fatal myocardial infarction.